Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (301-310 of 775) with videos related to

Pageof 78
Sort By:
Neuropsychologia|June 24, 2015
Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 statusMatthew A Albrecht, Cassandra Szoeke, Paul Maruff, et al.
Scientific Reports|March 4, 2026
Decreased metallothionein-3 expression in the human spinal cord is a common feature of amyotrophic lateral sclerosis and multiple sclerosisAdam P Gunn, James B W Hilton, Soumya Mukherjee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 30, 2025
Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's diseaseYing Xia, Pierrick Bourgeat, Vincent Doré, et al.
Communicable Diseases Intelligence (2018)|March 24, 2025
Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2023Christiane Stehmann, Matteo Senesi, Shannon Sarros, et al.
Brain : a Journal of Neurology|June 6, 2013
Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle StudyJonathan K Foster, Matthew A Albrecht, Greg Savage, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 19, 2007
A primer of amyloid nomenclaturePer Westermark, Merrill D Benson, Joel N Buxbaum, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 10, 2022
Plasma microRNA vary in association with the progression of Alzheimer's diseaseDiane Guévremont, Helen Tsui, Robert Knight, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Mesial temporal tau pathology impacts basal forebrain degeneration in early Alzheimer's diseaseYing Xia, Matthew W Dean, Pierrick Bourgeat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersYing Xia, Vincent Dore, Jurgen Fripp, et al.
Journal of Alzheimer'S Disease : JAD|August 30, 2024
A Comparison of an Australian Observational Longitudinal Alzheimer's Disease Cohort to Community-Based Australian DataAndrew Liem Hieu Huynh, Yihan Wang, Liwei Ma, et al.
Pageof 78

Showing results (301-310 of 775) with videos related to

Sort By:
Pageof 78
Neuropsychologia|June 24, 2015
Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 statusMatthew A Albrecht, Cassandra Szoeke, Paul Maruff, et al.
Scientific Reports|March 4, 2026
Decreased metallothionein-3 expression in the human spinal cord is a common feature of amyotrophic lateral sclerosis and multiple sclerosisAdam P Gunn, James B W Hilton, Soumya Mukherjee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 30, 2025
Amyloid accumulation, brain atrophy, and cognitive decline in emergent Alzheimer's diseaseYing Xia, Pierrick Bourgeat, Vincent Doré, et al.
Communicable Diseases Intelligence (2018)|March 24, 2025
Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2023Christiane Stehmann, Matteo Senesi, Shannon Sarros, et al.
Brain : a Journal of Neurology|June 6, 2013
Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle StudyJonathan K Foster, Matthew A Albrecht, Greg Savage, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 19, 2007
A primer of amyloid nomenclaturePer Westermark, Merrill D Benson, Joel N Buxbaum, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 10, 2022
Plasma microRNA vary in association with the progression of Alzheimer's diseaseDiane Guévremont, Helen Tsui, Robert Knight, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Mesial temporal tau pathology impacts basal forebrain degeneration in early Alzheimer's diseaseYing Xia, Matthew W Dean, Pierrick Bourgeat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersYing Xia, Vincent Dore, Jurgen Fripp, et al.
Journal of Alzheimer'S Disease : JAD|August 30, 2024
A Comparison of an Australian Observational Longitudinal Alzheimer's Disease Cohort to Community-Based Australian DataAndrew Liem Hieu Huynh, Yihan Wang, Liwei Ma, et al.
Pageof 78